These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

491 related items for PubMed ID: 7860734

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. CTL responses of HLA-A2.1-transgenic mice specific for hepatitis C viral peptides predict epitopes for CTL of humans carrying HLA-A2.1.
    Shirai M, Arichi T, Nishioka M, Nomura T, Ikeda K, Kawanishi K, Engelhard VH, Feinstone SM, Berzofsky JA.
    J Immunol; 1995 Mar 15; 154(6):2733-42. PubMed ID: 7533182
    [Abstract] [Full Text] [Related]

  • 3. Patients with chronic hepatitis C have circulating cytotoxic T cells which recognize hepatitis C virus-encoded peptides binding to HLA-A2.1 molecules.
    Battegay M, Fikes J, Di Bisceglie AM, Wentworth PA, Sette A, Celis E, Ching WM, Grakoui A, Rice CM, Kurokohchi K.
    J Virol; 1995 Apr 15; 69(4):2462-70. PubMed ID: 7884894
    [Abstract] [Full Text] [Related]

  • 4. HLA A2 restricted cytotoxic T lymphocyte responses to multiple hepatitis B surface antigen epitopes during hepatitis B virus infection.
    Nayersina R, Fowler P, Guilhot S, Missale G, Cerny A, Schlicht HJ, Vitiello A, Chesnut R, Person JL, Redeker AG, Chisari FV.
    J Immunol; 1993 May 15; 150(10):4659-71. PubMed ID: 7683326
    [Abstract] [Full Text] [Related]

  • 5. Identification of immunodominant hepatitis C virus (HCV)-specific cytotoxic T-cell epitopes by stimulation with endogenously synthesized HCV antigens.
    Urbani S, Uggeri J, Matsuura Y, Miyamura T, Penna A, Boni C, Ferrari C.
    Hepatology; 2001 Jun 15; 33(6):1533-43. PubMed ID: 11391544
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Effect of interferon-alpha therapy on epitope-specific cytotoxic T lymphocyte responses in hepatitis C virus-infected individuals.
    Vertuani S, Bazzaro M, Gualandi G, Micheletti F, Marastoni M, Fortini C, Canella A, Marino M, Tomatis R, Traniello S, Gavioli R.
    Eur J Immunol; 2002 Jan 15; 32(1):144-54. PubMed ID: 11754355
    [Abstract] [Full Text] [Related]

  • 12. Identification of an enhancer agonist cytotoxic T lymphocyte peptide from human carcinoembryonic antigen.
    Zaremba S, Barzaga E, Zhu M, Soares N, Tsang KY, Schlom J.
    Cancer Res; 1997 Oct 15; 57(20):4570-7. PubMed ID: 9377571
    [Abstract] [Full Text] [Related]

  • 13. Characterization of an immunologically conserved epitope from hepatitis C virus E2 glycoprotein recognized by HLA-A2 restricted cytotoxic T lymphocytes.
    Sarobe P, Huarte E, Lasarte JJ, López-Díaz de Cerio A, García N, Borrás-Cuesta F, Prieto J.
    J Hepatol; 2001 Feb 15; 34(2):321-9. PubMed ID: 11281563
    [Abstract] [Full Text] [Related]

  • 14. New epitope peptides derived from hepatitis C virus (HCV) 2a which have the capacity to induce cytotoxic T lymphocytes in HLA-A2+ HCV-infected patients.
    Wang Y, Takao Y, Harada M, Yutani S, Ide T, Sata M, Itoh K, Yamada A.
    Microbiol Immunol; 2006 Feb 15; 50(11):857-65. PubMed ID: 17116980
    [Abstract] [Full Text] [Related]

  • 15. Human cytotoxic T lymphocytes stimulated by endogenously processed human papillomavirus type 11 E7 recognize a peptide containing a HLA-A2 (A*0201) motif.
    Tarpey I, Stacey S, Hickling J, Birley HD, Renton A, McIndoe A, Davies DH.
    Immunology; 1994 Feb 15; 81(2):222-7. PubMed ID: 8157270
    [Abstract] [Full Text] [Related]

  • 16. Immunogenic variation between multiple HLA-A*0201-restricted, Hepatitis C Virus-derived epitopes for cytotoxic T lymphocytes.
    Ohno S, Moriya O, Yoshimoto T, Hayashi H, Akatsuka T, Matsui M.
    Viral Immunol; 2006 Feb 15; 19(3):458-67. PubMed ID: 16987064
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Use of recombinant protein to identify a motif-negative human cytotoxic T-cell epitope presented by HLA-A2 in the hepatitis C virus NS3 region.
    Kurokohchi K, Akatsuka T, Pendleton CD, Takamizawa A, Nishioka M, Battegay M, Feinstone SM, Berzofsky JA.
    J Virol; 1996 Jan 15; 70(1):232-40. PubMed ID: 8523531
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 25.